Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogs: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2

5 years ago

Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogs: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2

Yan Yang, Xingxiang Gu, Gunda Ingrid Georg, Jon Hawkinson, Carolyn Kingsley, Joseph Tash, Erick Carlson, Vijayalaxmi Gupta, Ernst Schonbrunn, Jinyi Zhu

Analogs of N-butyl-1-deoxynojirimycin (NB-DNJ) were prepared and assayed for inhibition of ceramide-specific glucosyltransferase (CGT), non-lysosomal -glucosidase 2 (GBA2) and the lysosomal -glucosidase 1 (GBA1). Compounds 6a-6f that carry sterically demanding nitrogen substituents, and compound 14, devoid of the C3 and C5 hydroxyl groups present in DNJ/NB-DGJ (N-butyl-deoxygalactojirimycin showed no inhibitory activity for CGT or GBA2. Inversion of stereochemistry at C4 of N-(n-butyl)- and N-(n-nonyl)-DGJ (compounds 25) also led to a loss of activity in these assays. The aminocyclopentitols N-(n-butyl)- (36a), N-(n-nonyl)-4-amino-5-(hydroxymethyl)cyclopentane- (36b), and N-(1-(pentyloxy)methyl)adamantan-1-yl)-1,2,3-triol (36f), were selective inhibitors of GBA1 and GBA2 that did not inhibit CGT (>1mM) with the exception of 36f, which inhibited CGT with an IC50 of 1 mM. The N-butyl analog 36a was 1000-fold selective for inhibiting GBA1 over GBA2 (Ki values of 32 nM and 3.3 μM for GBA1 and GBA2, respectively). The N-nonyl analog 36b displayed a Ki of <<14 nM for GBA1 inhibition and a Ki of 43 nM for GBA2. The N-(1-(pentyloxy)methyl)adamantan-1-yl) derivative 36f had Ki values of ~16 nM and 14 nM for GBA1 and GBA2, respectively. The related N-bis-substituted aminocyclopentitols were significantly less potent inhibitors than their mono-substituted analogs. The aminocyclopentitol scaffold should hold promise for further inhibitor development.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/cmdc.201700558